Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Disease Reports
bone resorption
MeSH D001862 - bone resorption
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D001847:
Bone diseases
6 Companies
1 Drug
$
Success rate
D016723:
Bone remodeling
0 Companies
0 Drugs
Success rate
D001862:
Bone resorption
2 Companies
1 Drug
$
Success rate
D000387:
Ainhum
0 Companies
0 Drugs
Success rate
D010014:
Osteolysis
11 Companies
1 Drug
$
Success rate
D016301:
Alveolar bone loss
0 Companies
0 Drugs
Success rate
Events Timeline
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
Amgen
Denosumab
Prolia
2010-05-26
$4,316 M
Q4/23-Q3/24
Clinical Trials
Historical Success Rate
Phase 1
100
%
1/1
Phase 2
75
%
3/4
Phase 3
71
%
5/7
Approved:
3
Overall Success rate:
54%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Amgen
Denosumab
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use
